Tyson Bioresearch Incorporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tyson Bioresearch Incorporation with three other
pharmaceutical manufacturers in Asia:
BioSino Bio-technology and Science Inc
sales of 290.38 million Chinese Renmimbi [US$41.85 million]
OK Biotech Co Ltd
(856.55 million Taiwanese Dollars [US$26.98 million]
of which 100%
was Ok Biotech Co Ltd), and
Mizuho Medy Co Ltd
based in Japan
(4.08 billion Japanese Yen [US$35.35 million]
During the year ended December of 2015, sales at
Tyson Bioresearch Incorporation were 233.74 million Taiwanese Dollars (US$7.36 million).
increase of 31.8%
versus 2014, when the company's sales were 177.33 million Taiwanese Dollars.